NR4A1 and breast cancer: More aggressive breast cancers, and tumours not expressing ER or PR receptors only represent a small proportion of all breast tumours and epidemiological studies considering breast cancer as a single homogeneous disease might have failed to detect any effect due to the inclusion of a small number of aggressive tumours not expressing hormone receptors.